GGrantIndex
Sort

40,608 grants matching prostate cancer

Preclinical Efficacy and Intermediate Endpoint Assays

$1,016,408
Margie L. Clapper · Fox Chase Cancer Center · N01 · FY2010 · CA

Mechanism of Fish Oil Supplements in Prevention of Cancer

$1,016,259
Yong Q Chen · Wake Forest University Health Sciences · P01 · FY2009 · CA

Detroit Research on Cancer Survivors (Detroit ROCS)

$1,016,242
Ann G Schwartz · Wayne State University · U01 · FY2024 · CA

PROSTATE CANCER CLINICAL CONSORTIUM CLINICAL RESEARCH SITE: TARGETED THERAPIES

$1,015,607
Weill Medical College Of Cornell University · · FY2014 · Department of the Army

(2/2) TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership

$1,015,126
Joel Erblich · Hunter College · U54 · FY2022 · CA

CIDR - SEQUENCING SERVICES USING WHOLE EXOME SEQUENCING 20X FOR NCI (BEEBE-DIMMER)

$1,015,000
Kimberly F Doheny · Johns Hopkins University · N01 · FY2023 · HL

Tissue Processing-Sequencing Facility

$1,014,563
Cathy D Vocke · Division Of Basic Sciences - Nci · ZIC · FY2020 · CA

The Pacific Northwest Prostate Cancer SPORE

$1,014,522
Peter S Nelson · Fred Hutchinson Cancer Center · P50 · FY2021 · CA

Drug Development for Prostate Cancer and other Metastatic Processes

$1,014,238
William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Identification of epithelial tumor susceptibility genes

$1,013,657
Allan Balmain · University Of California, San Francisco · U01 · FY2008 · CA

Clinical Translation of an Anti-Metastatic Antibody for Breast Cancer Therapy

$1,013,625
Kate W Rittenhouse-Olson · For-Robin · R42 · FY2016 · CA

Stanford Molecular and Cellular Characterization Laboratory

$1,013,416
James D Brooks · Stanford University · U01 · FY2018 · CA

Scalable single-cell workflow for multiomic analyses of chromatin interactions, accessibility, gene expression and cell surface proteins to unravel mechanisms of cellular diversity

$1,013,363
Anthony Schmitt · Arima Genomics, Inc. · R44 · FY2023 · GM

Overhauser Enhanced Magnetic Resonance Imaging (OMRI)

$1,012,304
Murali Cherukuri · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Targeted Nanoparticles for Tempospatially Controlled Combination Chemotherapy

$1,012,220
Robert S Langer · Massachusetts Institute Of Technology · U54 · FY2012 · CA

Development of a prototype clinical theranostic platform combining Magnetic Particle Imaging (MPI) and Magnetic Fluid Hyperthermia (MFH) for the treatment of brain tumors

$1,012,220
Patrick Goodwill · Magnetic Insight, Inc. · R44 · FY2024 · CA

Genetic Epidemiology of Cancer

$1,011,986
Joan E. Bailey-Wilson · National Human Genome Research Institute · ZIA · FY2020 · HG

Development of a prototype clinical theranostic platform combining Magnetic Particle Imaging (MPI) and Magnetic Fluid Hyperthermia (MFH) for the treatment of brain tumors

$1,011,684
Patrick Goodwill · Magnetic Insight, Inc. · R44 · FY2023 · CA

PROSTATE CANCER CLINICAL TRIALS CONSORTIUM CLINICAL RESEARCH SITE: UNIVERSITY OF WASHINGTON

$1,011,673
University Of Washington · · FY2015 · Department of the Army

Liver Cancer Disparities in Alaska Native and American Indian People

$1,011,489
George Ioannou · University Of Washington · P20 · FY2021 · CA

Breast, Colorectal, and Ovary Cancer Clinical Validation Center

$1,011,430
Christopher I Li · Fred Hutchinson Cancer Research Center · U01 · FY2016 · CA

RACIAL, CULTURAL, AND DYADIC RELATIONSHIP FACTORS INFLUENCING TREATMENT DECISIONS ABOUT ACTIVE SURVEILLANCE FOR LOCALIZED PROSTATE CANCER

$1,011,418
Icahn School Of Medicine At Mount Sinai · · FY2017 · Department of the Army

1/3 Morehouse School of Medicine/Tuskegee University/University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership

$1,010,535
Brian M. Rivers · Morehouse School Of Medicine · U54 · FY2024 · CA

Leadership, Planning and Evaluation

$1,010,352
Alan Ashworth · University Of California, San Francisco · P30 · FY2025 · CA

EVALUATION OF ANDROGEN RECEPTOR FUNCTION IN PROSTATE CANCER PROGNOSIS AND THERAPEUTIC STRATIFICATION

$1,010,210
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. · · FY2011 · Department of Defense